Abstract: This study is done to determining the Incidence and Prognostic factors with
I. Introduction
Breast cancer is considered uncommon in young women and correlates with less favorable prognosis; still it is the most frequent cancer in women under 40 yrs. [1, 2] As incidence of breast malignancy in young females increasing promptly the present study is aimed with evaluating incidence and prognosis of breast cancer in females ≤40 yrs.
II. Aims And Objectives
The present study aimed to evaluate incidence of breast malignancy in females ≤ 40yrs of age and to evaluate prognosis through tumor size, histological grade and IHC i.e. ER/PR status.
III. Material And Methods
Patients:-In total, 88 female patients of breast malignancies are studied from August 2011 to August 2012. Out of them ≤ 40 years of age female patient affected by Breast malignancies are studied in details with tumor size, type, Histopathology grade and ER & PR status. Histopathological study:-Tumor size is measured in the surgical specimens before the preparation of histological sections. In the case of locally advanced carcinoma, in which size is measured by imaging techniques (mammography and ultrasound before chemotherapy). Tumors are subsequently classified into three groups according to size (< 2 cm, 2-5 cm, >5 cm). Specimens are also classified according to histological grades into Grade I (well differentiated), Grade II (moderately differentiated),Grade III (poorly differentiated) and histological types. Immunohistochemical study:-Immunohistochemistry is performed on representative paraffin wax embedded specimens from the main tumor. Histological sections are mounted on poly-L-lysine treated slides and IHC (ER/PR) is performed by standard method.
IV. Results
We studied total 88 cases of breast malignancies cases during one year (from August 2011 to August 2012) ( Figure No. 1) . Out of them, in 22 cases the age of patients is ≤ 40 years. So the incidence of breast malignancy in ≤ 40 years age group patients is 25% ( 
V. Discussion
The goal of the study is to detect the incidence of breast malignancies in younger female (≤ 40 years of age) and detect the prognosis with respect to ER & PR status. As comparison with previous studies incidence of breast malignancies in younger female is increase.
Author
Age Group Incidence I Guerra et al [3] < 35 years 5 Katherina Zabicki et al [4] ≤ 40 years 10 Hanna Fredholm et al [5] < 40 years 7 M. Colleoni et al [6] < 35 years 2 N. Kromanet et al [7] < 35 years 2 Present Study ≤ 40 years 25
Tumor size in young females in present study is 2 to 5cm is more common i.e. 61.90% and >5cm is 28.57%, which is more as compare with I Guerra et al [3] 45.37 % & 24.07 % and Hanna Fredholm et al [5] 35.05 % & 15.05 % respectively. In present study histological grade II is higher (47.36%) followed by grade I (26.31%) and grade III (26.31%), while in other studies I Guerra et al [3] and Hanna Fredholm et al [5] grade III is higher, which is 51.85% & 22.45% respectively. Immunohistochemistry of breast malignancies in young female in present study shows 47.36% ER/PR negative, which is comparable with I Guerra et al [3] 62.96% but higher than Hanna Fredholm et al [5] 27.85%. Breast cancer at a young age has been reported to have increasing incidence and a more aggressive biological behavior as compared to older patients. [8, 9] The striking data observed in present study indicating increasing incidence and unfavorable prognosis of breast cancer in young females(≤ 40 yrs).
VI. Conclusions
Significantly high incidence i.e. 25 % of breast malignancy was found. 61.90 % of cases had tumour size of 2-5 cm followed by 28.5 % of cases had > 5 cm of tumour size with only 9.52 % of cases had < 2 cm of tumour size. Most of the cases classified under histological grade II at the time of diagnosis. Significant cases i.e. 47.36 % are ER/PR -ve suggest unfavorable prognosis. Important Research:-Studies have suggested that mammogram and MRI screening are able to detect breast cancer in young female. [10] MRI combined with detection of BRCA 1 and BRCA 2 mutation carriers have high sensitivity for detecting breast cancer in young females. Striking Increase in incidence of breast malignancy in young females needs effective screening programs in young age. Younger women have more aggressive tumor biology than older so, early diagnosis help for effective intervention.
